Company
Cofactor Genomics
Predictive Diagnostics: Matching cancer patients to treatment
Also known as Cofactor Genomics, Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Customers
- healthcare systems
- Legal name
- Cofactor Genomics, Inc.
- cofactorgenomics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Crunchbase (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Cofactor Genomics is bringing precision medicine to immunotherapy by leading development of predictive diagnostics.
Funding snapshot
- Total raised
- $18.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $1.2M2023-07-20
Funding rounds
- Round, 2023
- $1.2M2023-07-20, SEC form D sold, 2 investors
- Round, 2021
- $6.9M2021-12-08, SEC form D sold, 9 investors
- Round, 2017
- $10.7M2017-06-14, SEC form D sold, 23 investors
Products
- Other
- OncoPrism
Loading relationship preview